The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers Within the Treatment System
Open accessAbstract
Even though evidence-based treatment for opioid use disorders (OUD) is effective, almost four in five Americans with OUD do not receive any form of treatment. The gap in access to evidence-based care, including treatment with medications for OUD, stems in part from barriers to change within the health care system. This paper includes nine key barriers that prevent access to evidence-based care, including stigma; inadequate clinical training; a dearth of addiction specialists; lack of integration of MOUD provision in practice; regulatory, statutory, and data sharing restrictions; and financial barriers. Action from a number of actors is urgently needed to address this crisis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Implicit bias in healthcare professionals: a systematic review
FitzGerald, C., & Hurst, S. (2017) · BMC Medical Ethics · doi:10.1186/s12910-017-0179-8 · Cited by 2,556
Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017) · BMJ · doi:10.1136/bmj.j1550 · Cited by 1,816 · cited 3×
“Treatment with methadone and buprenorphine has additional, well-established benefi ts. Methadone and buprenorphine substantially decrease the risk of overdose, opioid-related and all-cause mortality, and the spread of infectious diseases such as human immunodefi ciency virus (HIV) and hepatitis C virus (HCV)[6,7].”
Backgroundvan Boekel, L. C., Brouwers, E. P. M., van Weeghel, J., & Garretsen, H. F. L. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.02.018 · Cited by 1,810
Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3107 · Cited by 1,076 · cited 2×
“A study of more than 17,000 survivors of overdose in Massachusetts found only 6-17 percent received MOUD in the subsequent year [62].”
BackgroundLivingston, J. D., Milne, T., Fang, M. L., & Amari, E. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03601.x · Cited by 927
Madras, B. K., Compton, W. M., Avula, D., Stegbauer, T., Stein, J. B., & Clark, H. W. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.003 · Cited by 663 · cited 1×
“Positive screens can be addressed with offi ce-based MOUD or referral to specialty care [38].”
BackgroundSelf-citationGeographic Variation in the Supply of Selected Behavioral Health Providers
Andrilla, C. H. A., Patterson, D. G., Garberson, L. A., Coulthard, C., & Larson, E. H. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.01.004 · Cited by 419 · cited 1×
“At the time of this paper’s publication, there were inadequate numbers of • Mental health and addiction medicine professionals [20,41], • Psychiatrists with specialized training in addiction [44,45,46,67,141,142], • Behavioral health counselors [17,66,67,143], and • Advanced practice clinicians certifi ed to provide M…”
BackgroundDevelopment of a Cascade of Care for responding to the opioid epidemic.
Williams, A. R., Nunes, E. V., Bisaga, A., Levin, F. R., & Olfson, M. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2018.1546862 · Cited by 332
Hammarlund, R. A., Crapanzano, K. A., Luce, L., Mulligan, L. A., & Ward, K. M. (2018) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s183256 · Cited by 330 · cited 2×
“• Stigma is associated with greater support for punitive policies, denial of services, and reluctance to engage in treatment [12,13,14].”
BackgroundTelemedicine-delivered treatment interventions for substance use disorders: A systematic review
Lin, L. (., Casteel, D., Shigekawa, E., Weyrich, M. S., Roby, D. H., & McMenamin, S. B. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.03.007 · Cited by 291
Cited by
Projected estimates of opioid mortality after community-level interventions.
Linas, B. P., Savinkina, A., Madushani, R. W. M. A., Wang, J., Eftekhari Yazdi, G., Chatterjee, A., Walley, A. Y., Morgan, J. R., Epstein, R. L., Assoumou, S. A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.37259 · Cited by 72
US payment policy for medications to treat opioid use disorder: landscape and opportunities
McGinty, E. E., White, S. A., Eisenberg, M. D., Palmer, N. R., Brown, C. H., & Saloner, B. K. (2024) · Health Affairs Scholar · doi:10.1093/haschl/qxae024 · Cited by 15
Bhondoekhan, F., Li, Y., Hallowell, B. D., Mahoney, L., Daly, M. M., Goulet, J., Beaudoin, F. L., Chambers, L. C., & Marshall, B. D. L. (2024) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2024.100287 · Cited by 4
“…consideration of patients ’ SUD treatment history and prior experience with healthcare access barriers might aid in connecting them with the appropriate ED behavioral services and increase their likelihood of engaging in SUD treatment post-discharge (Madras et al., 2020; Volkow and Blanco, 2021).”
BackgroundNaz, F., Shuja, K. H., Aqeel, M., Ehsan, S., Noor, A., Butt, D., Gul, H., Rafaqat, U., Khan, A., & Gulzamir, S. (2021) · International Journal of Human Rights in Healthcare · doi:10.1108/ijhrh-12-2020-0127 · Cited by 1
Metadata
- Authors
- Madras, B. K., Ahmad, N. J., Wen, J., Sharfstein, J., & Prevention, T.
- Venue
- NAM Perspectives
- Publisher
- National Academy of Medicine
- Published
- 2020-04-27
- Volume
- 2020
- ISSN
- 2578-6865 (ISSN-L)
- OpenAlex
- W3019524946
- Cited by
- 239
- References
- 13
- FWCI
- 21.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.